معرفی
Dima Kuzmin is an Adjunct Assistant Professor in the Department of Medicine (Medical Oncology and Hematology) at Yale School of Medicine. He specializes in clinical trial design, post-registrational assessment, and ethical access to curative therapies like gene and cell therapy. His research integrates neurochemistry, tool development for CNS gene therapy, and biotechnology entrepreneurship.
- Education:
- MSc in Experimental Therapeutics, University of Oxford (2018)
- PhD in Neurochemistry, Russian Academy of Sciences & MPIH Frankfurt (2011)
- Postdoctoral Fellow, University College London Institute of Neurology (2017)
- Affiliations:
- Managing Partner at 4BIO Capital (venture capital for advanced therapies)
- Board Member at Redpin Therapeutics, Araris Biotech, and others
- Co-founder of non-profit Future Biotech
His research focuses on translating neurochemical insights into clinical applications, including optogenetics/chemogenetics for brain-computer interfaces and ethical frameworks for curative therapies.
- Awards:
- Fellow of the Royal Society of Biology (2021)
- Kauffman Fellow
Dr. Kuzmin advises multiple biotech startups and actively promotes entrepreneurship in Central/Eastern Europe through educational initiatives.
۰مقاله منتشرشده
